A cancer survivor recently discovered he could sell his life insurance policy to investors—a practice that has evolved into a multibillion-dollar market known as life settlements. Under this arrangement, policyholders sell their policies for a percentage of the face value, typically 20 to 30 cents on the dollar, while investors assume premium payments and collect the full payout upon the policyholder’s death. The discovery prompted the policyholder to investigate further after learning that companies making these purchases seek rapid returns on their investments.
The legal framework enabling this market traces back to a Supreme Court decision from 1911, when the court ruled that life insurance policies could be treated as personal property and sold to other parties, provided the original policyholder had insurable interest when the policy was established. This principle prevented individuals from taking out policies on strangers, which would create perverse incentives for harm. However, the ruling allowed those with legitimate policies to transfer them as assets.
Despite this early legal precedent, the life settlement market did not materialize immediately. The industry’s emergence in the late 1980s coincided with the AIDS crisis, when individuals facing terminal illness and financial hardship sought alternatives to cover mounting costs. One early participant in this nascent market was a man whose partner was dying of AIDS and had stopped working due to illness progression, creating urgent financial need.
Today, the market has evolved into an abstract financial instrument, with major investment firms accumulating portfolios of policies on numerous individuals. These consolidated holdings represent significant capital deployed while investors await returns from mortality events, effectively transforming end-of-life timelines into tradable financial assets managed by Wall Street institutions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI